| TX | SB629 | Pass | Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
[Detail][Text][Discuss] | 2023-06-18
Effective immediately |
| TX | SB2479 | Pass | Relating to procedures regarding certain persons who are or may be persons with a mental illness or intellectual disability.
[Detail][Text][Discuss] | 2023-06-18
Effective on 9/1/23 |
| TX | SB773 | Pass | Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
[Detail][Text][Discuss] | 2023-06-18
Effective immediately |
| TX | SB867 | Pass | Relating to the recipients of opioid antagonists under the opioid antagonist program.
[Detail][Text][Discuss] | 2023-06-17
Effective immediately |
| TX | HB4888 | Pass | Relating to Medicaid coverage and reimbursement for non-opioid treatments.
[Detail][Text][Discuss] | 2023-06-13
Effective on 9/1/23 |
| TX | HB4990 | Pass | Relating to the Texas Pharmaceutical Initiative and a governing board and advisory council for the initiative.
[Detail][Text][Discuss] | 2023-06-13
Effective immediately |
| TX | HB25 | Pass | Relating to wholesale importation of prescription drugs in this state; authorizing a fee.
[Detail][Text][Discuss] | 2023-06-12
Effective on 9/1/23 |
| TX | HB755 | Pass | Relating to prior authorization for prescription drug benefits related to the treatment of autoimmune diseases and certain blood disorders.
[Detail][Text][Discuss] | 2023-06-12
Effective on 9/1/23 |
| TX | HB1337 | Pass | Relating to step therapy protocols required by health benefit plans for coverage of prescription drugs for serious mental illnesses.
[Detail][Text][Discuss] | 2023-06-12
Effective on 9/1/23 |
| TX | HB3286 | Pass | Relating to prescription drug benefits under Medicaid and the child health plan program.
[Detail][Text][Discuss] | 2023-06-12
Effective on 9/1/23 |
| TX | HB4166 | Pass | Relating to the packaging requirements for certain donated prescription drugs.
[Detail][Text][Discuss] | 2023-06-12
Effective on 9/1/23 |
| TX | HB4331 | Pass | Relating to the donors of certain unused prescription drugs.
[Detail][Text][Discuss] | 2023-06-12
Effective on 9/1/23 |
| TX | HB4332 | Pass | Relating to the redistribution of donated prepackaged prescription drugs.
[Detail][Text][Discuss] | 2023-06-12
Effective on 9/1/23 |
| TX | HB999 | Pass | Relating to the effect of certain reductions in a health benefit plan enrollee's out-of-pocket expenses for certain prescription drugs on enrollee cost-sharing requirements.
[Detail][Text][Discuss] | 2023-06-10
Effective on 9/1/23 |
| TX | HB1283 | Pass | Relating to prescription drug formularies applicable to the Medicaid managed care program.
[Detail][Text][Discuss] | 2023-06-10
Effective on 9/1/23 |
| TX | HB1647 | Pass | Relating to health benefit plan coverage of clinician-administered drugs.
[Detail][Text][Discuss] | 2023-06-09
Effective on 9/1/23 |
| TX | SB1179 | Pass | Relating to sexually violent predators and the prosecution of certain offenses involving prohibited items at correctional or civil commitment facilities; creating a criminal offense.
[Detail][Text][Discuss] | 2023-06-02
Effective on 9/1/23 |
| TX | SB622 | Pass | Relating to the disclosure of certain prescription drug information by a health benefit plan.
[Detail][Text][Discuss] | 2023-05-29
Effective on 9/1/23 |
| TX | SB2173 | Pass | Relating to a pilot program for the safe disposal of prescription drugs, including controlled substance prescription drugs.
[Detail][Text][Discuss] | 2023-05-29
Effective on 9/1/23 |
| TX | SB241 | Pass | Relating to written notification provided by drug manufacturers regarding the cause of generic or biosimilar insulin prescription drug unavailability.
[Detail][Text][Discuss] | 2023-05-27
Effective on . . . . . . . . . . . . . . . September 1, 2024 |
| TX | SB294 | Pass | Relating to the use of epinephrine auto-injectors and medication designated for treatment of respiratory distress on public and private school campuses.
[Detail][Text][Discuss] | 2023-05-24
Effective immediately |
| TX | HB3338 | Engross
Sine Die | Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.
[Detail][Text][Discuss] | 2023-05-24
Removed from local & uncontested calendar |
| TX | SB2527 | Engross
Sine Die | Relating to the regulation of telemedicine medical services, teledentistry services, and telehealth services; providing a civil penalty.
[Detail][Text][Discuss] | 2023-05-18
To House Public Health Committee |
| TX | HB3346 | Engross
Sine Die | Relating to the administration of medication to certain persons in the custody of a sheriff.
[Detail][Text][Discuss] | 2023-05-12
Received from the House |
| TX | HB638 | Intro
Sine Die | Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.
[Detail][Text][Discuss] | 2023-05-11
Laid on the table subject to call |
| TX | HB1190 | Engross
Sine Die | Relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.
[Detail][Text][Discuss] | 2023-05-11
To Senate Health & Human Services Committee |
| TX | HB2716 | Engross
Sine Die | Relating to neglect of a child and the grounds for termination of the parent-child relationship and possession of a child by the Department of Family and Protective Services.
[Detail][Text][Discuss] | 2023-05-11
To Senate Health & Human Services Committee |
| TX | HB4059 | Engross
Sine Die | Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.
[Detail][Text][Discuss] | 2023-05-11
To Senate Health & Human Services Committee |
| TX | HB2180 | Intro
Sine Die | Relating to the application of prescription drug price rebates to reduce health benefit plan enrollee cost sharing.
[Detail][Text][Discuss] | 2023-05-10
Placed on General State Calendar |
| TX | HB3026 | Engross
Sine Die | Relating to the administration of a prescription drug manufacturer or third-party prescription assistance program.
[Detail][Text][Discuss] | 2023-05-10
To Senate Health & Human Services Committee |
| TX | HB1754 | Intro
Sine Die | Relating to the disclosure of certain prescription drug information by a health benefit plan.
[Detail][Text][Discuss] | 2023-05-09
Laid on the table subject to call |
| TX | HB2767 | Engross
Sine Die | Relating to the sharing of controlled substance prescription monitoring information between the Texas State Board of Pharmacy and the Health and Human Services Commission for the state Medicaid program.
[Detail][Text][Discuss] | 2023-05-09
To Senate Health & Human Services Committee |
| TX | HB1240 | Intro
Sine Die | Relating to the authority of a physician to provide and dispense and to delegate authority to provide and dispense certain drugs.
[Detail][Text][Discuss] | 2023-05-06
Committee report sent to Calendars |
| TX | SB2212 | Engross
Sine Die | Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.
[Detail][Text][Discuss] | 2023-05-06
To House Public Health Committee |
| TX | HB920 | Intro
Sine Die | Relating to the use of medication designated for treatment of respiratory distress on public and private school campuses.
[Detail][Text][Discuss] | 2023-05-05
Laid on the table subject to call |
| TX | HB2529 | Intro
Sine Die | Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.
[Detail][Text][Discuss] | 2023-05-01
To House Public Health Committee |
| TX | HB4058 | Engross
Sine Die | Relating to the use of opioid antagonists on the campuses of public and private schools and institutions of higher education and at or in transit to or from off-campus school events.
[Detail][Text][Discuss] | 2023-05-01
To Senate Education Committee |
| TX | SB301 | Engross
Sine Die | Relating to prescribing, administering, or dispensing ivermectin or hydroxychloroquine sulfate.
[Detail][Text][Discuss] | 2023-04-28
To House Public Health Committee |
| TX | HB2891 | Engross
Sine Die | Relating to the use of glucagon medication on certain public and private school campuses.
[Detail][Text][Discuss] | 2023-04-27
To Senate Education Committee |
| TX | SB1113 | Intro
Sine Die | Relating to prescription drug formularies applicable to the Medicaid managed care program.
[Detail][Text][Discuss] | 2023-04-26
To Senate Health & Human Services Committee |
| TX | SB1150 | Intro
Sine Die | Relating to prior authorization for prescription drug benefits related to the treatment of chronic and autoimmune diseases.
[Detail][Text][Discuss] | 2023-04-26
To Senate Health & Human Services Committee |
| TX | SB1619 | Intro
Sine Die | Relating to the determination of prescription drug reimbursement amounts under the Medicaid vendor drug program.
[Detail][Text][Discuss] | 2023-04-26
To Senate Health & Human Services Committee |
| TX | HB826 | Intro
Sine Die | Relating to modification of certain prescription drug benefits and coverage offered by certain health benefit plans.
[Detail][Text][Discuss] | 2023-04-25
To House Insurance Committee |
| TX | HB1293 | Intro
Sine Die | Relating to the reimbursement of prescription drugs under Medicaid and the child health plan program.
[Detail][Text][Discuss] | 2023-04-25
To House Human Services Committee |
| TX | HB3715 | Intro
Sine Die | Relating to access to all prescribed medications by residents in certain long-term care facilities.
[Detail][Text][Discuss] | 2023-04-25
To House Human Services Committee |
| TX | HB2411 | Engross
Sine Die | Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.
[Detail][Text][Discuss] | 2023-04-24
To Senate Education Committee |
| TX | HB2743 | Intro
Sine Die | Relating to procedures regarding the court-ordered administration of psychoactive medication for criminal defendants who are found incompetent to stand trial.
[Detail][Text][Discuss] | 2023-04-24
To House Corrections Committee |
| TX | HB4886 | Intro
Sine Die | Relating to sexually violent predators and the prosecution of certain offenses involving prohibited items at correctional or civil commitment facilities; creating a criminal offense.
[Detail][Text][Discuss] | 2023-04-24
To House Corrections Committee |
| TX | SB1138 | Intro
Sine Die | Relating to health benefit plan coverage of clinician-administered drugs.
[Detail][Text][Discuss] | 2023-04-19
To Senate Health & Human Services Committee |
| TX | SB2402 | Intro
Sine Die | Relating to the creation, management, and administration of the Texas Pharmaceutical Initiative.
[Detail][Text][Discuss] | 2023-04-19
To Senate Health & Human Services Committee |
